Issue 73 | August 2018

Genentech has signed a $1bn open-ended drug discovery collaboration with Lodo Therapeutics to discover unique, natural products from the microbial DNA found in soil. With this level of investment confidence must be high, but just how much potential lies in soil, and how can it be harnessed?

We also explore whether a cannabinoids breakthrough signals hope for epilepsy treatment, find out about an innovative approach to cancer research and clinical trials from the University of Texas MD Anderson Cancer Center, and following the launch of a programme to add novel treatments to Novartis' malaria pipeline we take a look at the need for new antimalarials. 

Finally, we examine the latest requirements for freight hubs that prepare pharma products for transport by air and following the FDA's decision to publicly list the names of pharma companies that may have been denying access to reference samples for generic drug manufacturers, we ask if this 'name and shame' approach is justified.


Editor | Eloise McLennan
Group Editor | Susanne Hauner

Commissioning Editor | Daniel Garrun

Writers | Elly Earls, Chris Lo, Abi Millar
Magazine Designer | Marzia Del Gaone

Graphic Designers | Paulius Zutautas, Francesco Cianciulli, Marzia Compassi, Kate Cuntapay, Anett Arc, Sara Basto
Lead Designer | John Hammond 
Digital Publishing Director | Duncan West


Sales Manager | Nimai Amin

+44 (0) 207 936 6453


Deputy Editor | Callum Tyndall

Pharma Technology focus is powered by h5mag

read past issues of pharma technology focus HERE

Pharma Technology Focus is a product of Net Resources International. Copyright 2018 Net Resources International, a trading division of Kable Intelligence Limited. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registrationnumber 03171601.

All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.